ARMP
Price
$1.98
Change
+$0.02 (+1.02%)
Updated
Jun 6 closing price
Capitalization
71.66M
67 days until earnings call
SLN
Price
$5.44
Change
+$0.03 (+0.55%)
Updated
Jun 6 closing price
Capitalization
225.29M
Interact to see
Advertisement

ARMP vs SLN

Header iconARMP vs SLN Comparison
Open Charts ARMP vs SLNBanner chart's image
Armata Pharmaceuticals
Price$1.98
Change+$0.02 (+1.02%)
Volume$7.3K
Capitalization71.66M
Silence Therapeutics
Price$5.44
Change+$0.03 (+0.55%)
Volume$213.96K
Capitalization225.29M
ARMP vs SLN Comparison Chart
Loading...
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARMP vs. SLN commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a Hold and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (ARMP: $1.98 vs. SLN: $5.44)
Brand notoriety: ARMP and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 2% vs. SLN: 97%
Market capitalization -- ARMP: $71.66M vs. SLN: $225.29M
ARMP [@Biotechnology] is valued at $71.66M. SLN’s [@Biotechnology] market capitalization is $225.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLN is a better buy in the long-term than ARMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARMP’s TA Score shows that 5 TA indicator(s) are bullish while SLN’s TA Score has 4 bullish TA indicator(s).

  • ARMP’s TA Score: 5 bullish, 5 bearish.
  • SLN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ARMP is a better buy in the short-term than SLN.

Price Growth

ARMP (@Biotechnology) experienced а +1.54% price change this week, while SLN (@Biotechnology) price change was -6.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

ARMP is expected to report earnings on Aug 13, 2025.

SLN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLN($225M) has a higher market cap than ARMP($71.7M). ARMP YTD gains are higher at: 7.027 vs. SLN (-20.930). ARMP has higher annual earnings (EBITDA): -31.21M vs. SLN (-71.65M). SLN has more cash in the bank: 137M vs. ARMP (17.1M). SLN has less debt than ARMP: SLN (60K) vs ARMP (140M). SLN has higher revenues than ARMP: SLN (27.7M) vs ARMP (0).
ARMPSLNARMP / SLN
Capitalization71.7M225M32%
EBITDA-31.21M-71.65M44%
Gain YTD7.027-20.930-34%
P/E RatioN/AN/A-
Revenue027.7M-
Total Cash17.1M137M12%
Total Debt140M60K233,333%
FUNDAMENTALS RATINGS
ARMP: Fundamental Ratings
ARMP
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARMPSLN
RSI
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
78%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
86%
Bullish Trend 10 days ago
89%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ARMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MLP16.860.28
+1.69%
Maui Land & Pineapple Co
VANI1.150.01
+0.88%
Vivani Medical
BA210.801.78
+0.85%
Boeing Company
BBIO38.620.28
+0.73%
BridgeBio Pharma
HTO51.30-0.70
-1.35%
H2O America

ARMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARMP has been loosely correlated with PTIX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ARMP jumps, then PTIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
+1.02%
PTIX - ARMP
44%
Loosely correlated
+3.87%
TNGX - ARMP
31%
Poorly correlated
+21.37%
BOLT - ARMP
29%
Poorly correlated
-0.25%
CTNM - ARMP
28%
Poorly correlated
+14.46%
SLN - ARMP
26%
Poorly correlated
+0.55%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+0.55%
CLLS - SLN
43%
Loosely correlated
-2.08%
CMVLF - SLN
38%
Loosely correlated
N/A
IDYA - SLN
36%
Loosely correlated
+2.99%
ABCZF - SLN
36%
Loosely correlated
N/A
NGNE - SLN
36%
Loosely correlated
-4.76%
More